No7 Lift and Luminite Day Cream SPF 15

Manufacturer
BCM Ltd | The Boots Company PLC
Effective date
2014-09-15
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-05-31 22:40:19

Label at a glance#

ProductNo7 Lift and Luminite Day Cream SPF 15
Active ingredientAVOBENZONE, OCTINOXATE, OCTOCRYLENE
Label structure12 sections

Indications and uses

Uses - helps prevent sunburn

Dosage and administration

Directions Apply liberally 15 minutes before sun exposure reapply at least every 2 hours use a water resistnat sunscreen if swimming or sweating children under 6 months of age: Ask a doctor Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protectio...

Storage and handling

Other information Protect the product in this container from excessive heat and direct sun

Label contents#

Full prescribing information#

Carton Active Ingredients Section

OTC - ACTIVE INGREDIENT SECTION

Active ingredients

Avobenzone 3%

Octinoxate 6%

Octocrylene 1%

Uses

OTC - PURPOSE SECTION

Uses - helps prevent sunburn

Warnings

WARNINGS AND PRECAUTIONS SECTION

For external use only

Do not use on damaged or broken skin

When using this product keep out of eyes. Rinse with water to remove.

Ask a doctor

OTC - ASK DOCTOR SECTION

Stop use and ask a doctor if rash occurs

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away

Directions

INDICATIONS & USAGE SECTION

Directions

Apply liberally 15 minutes before sun exposure

reapply at least every 2 hours

use a water resistnat sunscreen if swimming or sweating

children under 6 months of age: Ask a doctor

Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging.

To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:

Limit time in the sun, especially from 10 a.m - 2 p.m.

wear long-sleeved shirts,pants,hats and sunglasses.

Storage

STORAGE AND HANDLING SECTION

Other information

Protect the product in this container from excessive heat and direct sun

Inactive ingredients

INACTIVE INGREDIENT SECTION

Aqua(Water), Glycerin, C12-15 alkyl  benzoate, Butyrospermum parkii(Shea) butter, butylene glycol, cetearyl glucoside, C18-36 acid glycol ester, Dimethicone, Mica, Cetearyl alcohol, Cyclopentasiloxane, Ammonium acryloydimethyltaurate/VP copolymer, Phenoxyethanol, Cyclohexasiloxane, Potassium cetyl phosphate, Dipalmitoyl hydroxyproline, Xanthan gum, Methylparaben, Sodium ascorbyl phosphate, Dimethiconol, Parfum( fragrance), Ethylparaben, Dipropylene glycol, Tetrasodium EDTA, Citric acid, T-buytl alcohol, Lupinus albus seed extract, Carbomer, Polysorbate-20, Haeamatococcus pluvialis powder, BHT, Polyglucuronic acid, Potassium sorbate, Silica, Butylparaben, Propylparaben, Isobutylparaben, Palmitoyl tripeptide-1, Palmitoyl tetrapeptide-7, Biotin, CI 77891 ( Titanium dioxide)

INFORMATION FOR PATIENTS SECTION

Made in the UK

The Boots Company PLC Nottingham England NG2 3AA

Dist. by Boots Retail USA Inc. Norwalk CT 06851 USA

www.boots.com

DESCRIPTION SECTION

Lift and Luminate Skincare System

The No7 Lift and Luminate Skincare System targets 3 key signs of aging in mature skin: wrinkles, loss of firmness and uneven skin tone. With Peptide technology to help deliver visible firming benefitss to your skin in as little as 4 weeks.

Key Ingredients

Matrixyl 3000 and Retinyl palmitate ( Pro-retinol) to help reduce the appearance of wrinkles and provide firmer feeling skin.

Sophora and Kiwi extracts to help provide a more even skin tone - enhanced by a Poly-hydroxyacid in the night serum.

Vitamin C, Hawaiian algae, Lipoaminoacid - an energising complex to help older skin behave like younger skin and leave skin looking brighter and younger, with a more even skin tone.

Shea butter moisturizes and noursihes the skin leaving it softer and smoother

Sunscreen Broad Spectrum SPF 15 helps to provide protection against the aging effects of the sun when used as directed with other sun protection measures.

What is the No7 Lift and Luminate Skincare System?

An advanced skincare system consisting of day and night serum, a day cream and a night cream for firmer feeling and more radiant-looking skin in just 4 weeks. Suitable for all skin types, it is ideal for those with deeper lines and wrinkles who are looking for a more youthful appearance.

How do I use it?

Smooth No7 Lift and Luminate Day Serum onto face and neck with your finger tips, followed by No7 Lift and Luminate Day Cream. At night, follow your No7 Lift and Luminate Night Serum application with No7 Lift and Luminate Night Cream, to moisturise and improve the appearance of deeper lines and wrinkles while you sleep.

What should I use with these products?

To complete your beauty regime use No7 Lift and Luminate Eye Cream, specially developed to help brighten, smooth and leave delicate skin around the eyes feeling firmer.

carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

No7LandLSkincareSystem2014No7LandLSkincareSystem2014

Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

No7LandLSkincareSystem2014No7LandLSkincareSystem2014

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
11489-087-012019-11-27C16284748780-19855e2a2-38eb-60a7-e053-dbdaa90a05bdNo7 Lift and Luminate Day Cream SPF 15

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
11489-087-01No7 Lift and Luminite Day Cream SPF 1550 g in 1 JARCREAM504
11489-087-01No7 Lift and Luminite Day Cream SPF 151 in 1 CARTONCREAM14

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
11489-087NO7 LIFT AND LUMINITE DAY CREAM SPF 15 (AVOBENZONE,OCTINOXATE, OCTOCRYLENE) CREAM [BCM LTD]4Legacy NDC, 2 package rows20140926_7914cbe6-4fd5-42a7-8b46-aed65b4cc2ef.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
AVOBENZONEACTIVE INGREDIENTG63QQF2NOX4
OCTINOXATEACTIVE INGREDIENT4Y5P7MUD514
OCTOCRYLENEACTIVE INGREDIENT5A68WGF6WM4
AVOBENZONEACTIVE MOIETYG63QQF2NOX4
OCTINOXATEACTIVE MOIETY4Y5P7MUD514
OCTOCRYLENEACTIVE MOIETY5A68WGF6WM4
AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMERINACTIVE INGREDIENTW59H9296ZG4
BIOTININACTIVE INGREDIENT6SO6U10H044
BUTYLATED HYDROXYTOLUENEINACTIVE INGREDIENT1P9D0Z171K4
BUTYLENE GLYCOLINACTIVE INGREDIENT3XUS85K0RA4
BUTYLPARABENINACTIVE INGREDIENT3QPI1U3FV84
C12-15 ALKYL BENZOATEINACTIVE INGREDIENTA9EJ3J61HQ4
CARBOMER 940INACTIVE INGREDIENT4Q93RCW27E4
CETEARYL GLUCOSIDEINACTIVE INGREDIENT09FUA47KNA4
CETOSTEARYL ALCOHOLINACTIVE INGREDIENT2DMT128M1S4
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QP4
CYCLOMETHICONE 5INACTIVE INGREDIENT0THT5PCI0R4
CYCLOMETHICONE 6INACTIVE INGREDIENTXHK3U310BA4
DIMETHICONEINACTIVE INGREDIENT92RU3N3Y1O4
DIMETHICONOL (100000 CST)INACTIVE INGREDIENTOSA9UP217S4
DIPALMITOYL HYDROXYPROLINEINACTIVE INGREDIENTE6AHA53N1H4
DIPROPYLENE GLYCOLINACTIVE INGREDIENTE107L85C404
EDETATE SODIUMINACTIVE INGREDIENTMP1J8420LU4
ETHYLPARABENINACTIVE INGREDIENT14255EXE394
GLYCERININACTIVE INGREDIENTPDC6A3C0OX4
HAEMATOCOCCUS PLUVIALISINACTIVE INGREDIENT31T0FF04724
ISOBUTYLPARABENINACTIVE INGREDIENT0QQJ25X58G4
LUPINUS ALBUS SEEDINACTIVE INGREDIENT24GB753W3B4
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9T4
MICAINACTIVE INGREDIENTV8A1AW08804
PALMITOYL OLIGOPEPTIDEINACTIVE INGREDIENTHO4ZT5S86C4
PALMITOYL TETRAPEPTIDE-7INACTIVE INGREDIENTQ41S464P1R4
PHENOXYETHANOLINACTIVE INGREDIENTHIE492ZZ3T4
POLYSORBATE 20INACTIVE INGREDIENT7T1F30V5YH4
POTASSIUM CETYL PHOSPHATEINACTIVE INGREDIENT03KCY6P7UT4
POTASSIUM SORBATEINACTIVE INGREDIENT1VPU26JZZ44
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OH4
SHEA BUTTERINACTIVE INGREDIENTK49155WL9Y4
SODIUM ASCORBYL PHOSPHATEINACTIVE INGREDIENT836SJG51DR4
TERT-BUTYL ALCOHOLINACTIVE INGREDIENTMD83SFE9594
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JP4
WATERINACTIVE INGREDIENT059QF0KO0R4
XANTHAN GUMINACTIVE INGREDIENTTTV12P4NEE4

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 2 · 42 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
11489-08711489-087-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 40 matching rows.

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 9 · 523 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION, POWDER, FOR SOLUTION / INTRAMUSCULARNAExact identifier — unii candidate
88 equally ranked IID candidates
CETOSTEARYL ALCOHOLCETOSTEARYL ALCOHOL2DMT128M1SCAPSULE, EXTENDED RELEASE / ORAL9.43 mgExact identifier — unii candidate
9 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION / INFILTRATION0.02 %w/vExact identifier — unii candidate
88 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPOINTMENT / TOPICAL5 %w/wExact identifier — unii candidate
40 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPGRANULE, FOR SUSPENSION / ORAL143 mgExact identifier — unii candidate
40 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHEMULSION / TOPICAL0.06 %w/wExact identifier — unii candidate
68 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSOLUTION / TOPICAL24 mgExact identifier — unii candidate
68 equally ranked IID candidates
CYCLOMETHICONE 5CYCLOMETHICONE 50THT5PCI0RAEROSOL / TOPICAL2.5 %w/wExact identifier — unii candidate
3 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEESUSPENSION / RECTAL452 mgExact identifier — unii candidate
29 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSUPPOSITORY / VAGINALNAExact identifier — unii candidate
68 equally ranked IID candidates
TERT-BUTYL ALCOHOLTERT-BUTYL ALCOHOLMD83SFE959GEL / TOPICAL0.12 %w/wExact identifier — unii candidate
POLYSORBATE 20POLYSORBATE 207T1F30V5YHTABLET / ORAL17 mgExact identifier — unii candidate
28 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHINJECTION, SOLUTION / SUBCUTANEOUSNAExact identifier — unii candidate
28 equally ranked IID candidates
BUTYLPARABENBUTYLPARABEN3QPI1U3FV8SUSPENSION / ORAL12 mgExact identifier — unii candidate
15 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHLIQUID / ORAL2 mgExact identifier — unii candidate
68 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / TOPICAL1971 mgExact identifier — unii candidate
75 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPCAPSULE / ORAL238 mgExact identifier — unii candidate
88 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TEMULSION / TOPICAL0.2 %w/wExact identifier — unii candidate
79 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHTABLET, FILM COATED / ORAL0.35 mgExact identifier — unii candidate
28 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSUSPENSION / SUBCUTANEOUS0.02 %w/vExact identifier — unii candidate
68 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TGEL / TOPICAL24 mgExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION, SOLUTION / INTRAVENOUS45 mgExact identifier — unii candidate
79 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEESUSPENSION, EXTENDED RELEASE / ORAL186.8 mgExact identifier — unii candidate
29 equally ranked IID candidates
PHENOXYETHANOLPHENOXYETHANOLHIE492ZZ3TAEROSOL, FOAM / TOPICAL72 mgExact identifier — unii candidate
6 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPPOWDER, FOR SOLUTION / TOPICALNAExact identifier — unii candidate
88 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSOLUTION / NASAL140 mgExact identifier — unii candidate
68 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEESUSPENSION/ DROPS / ORAL22 mgExact identifier — unii candidate
29 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHOINTMENT / TOPICAL0.2 %w/wExact identifier — unii candidate
68 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION / INTRASYNOVIALADJ PHExact identifier — unii candidate
88 equally ranked IID candidates
CETOSTEARYL ALCOHOLCETOSTEARYL ALCOHOL2DMT128M1SCREAM / TOPICAL1428 mgExact identifier — unii candidate
9 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE / ORAL72 mgExact identifier — unii candidate
40 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPSUSPENSION / ORAL113 mgExact identifier — unii candidate
40 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHGEL / VAGINAL2 mgExact identifier — unii candidate
68 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL2 mgExact identifier — unii candidate
88 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION / INTRACARDIAC1.05 %w/vExact identifier — unii candidate
88 equally ranked IID candidates
CETOSTEARYL ALCOHOLCETOSTEARYL ALCOHOL2DMT128M1SOINTMENT / TOPICAL1.2 %w/wExact identifier — unii candidate
9 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHSUSPENSION / AURICULAR (OTIC)0.1 %w/vExact identifier — unii candidate
28 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSOLUTION / RECTAL0.13 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / NASAL25 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION, SUSPENSION / SUBCUTANEOUS1.6 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KCAPSULE, LIQUID FILLED / ORAL0.1 mgExact identifier — unii candidate
32 equally ranked IID candidates
POLYSORBATE 20POLYSORBATE 207T1F30V5YHGEL / TOPICAL5 %w/wExact identifier — unii candidate
28 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, ORALLY DISINTEGRATING / ORAL6 mgExact identifier — unii candidate
40 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXDROPS / ORAL300 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION, SOLUTION, CONCENTRATE / IRRIGATION1 mgExact identifier — unii candidate
88 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TJELLY / TOPICAL420 mgExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSOLUTION / INTRAVENOUS0.13 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION / INTRABURSALADJ PHExact identifier — unii candidate
88 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KSUPPOSITORY / VAGINALNAExact identifier — unii candidate
32 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSHAMPOO / TOPICAL0.15 %w/wExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION / INTRAMUSCULAR95 mgExact identifier — unii candidate
79 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPPOWDER, FOR SOLUTION / ORAL315 mgExact identifier — unii candidate
88 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION / INFILTRATION80 mgExact identifier — unii candidate
79 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSPONGE / TOPICAL2 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / OPHTHALMIC6 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXFILM, EXTENDED RELEASE / BUCCAL34 mgExact identifier — unii candidate
75 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION / PERINEURAL80 mgExact identifier — unii candidate
79 equally ranked IID candidates
POTASSIUM SORBATEPOTASSIUM SORBATE1VPU26JZZ4EMULSION / OPHTHALMIC0.47 %w/vExact identifier — unii candidate
19 equally ranked IID candidates
CARBOMER 940CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)4Q93RCW27EEMULSION / TOPICAL6 mgExact identifier — unii candidate
9 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / ORAL32400 mgExact identifier — unii candidate
75 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
bbdd3150-7f98-4dc6-b231-1c483292084a7914cbe6-4fd5-42a7-8b46-aed65b4cc2ef2014-09-15WarningsExact identifier
spl id: bbdd3150-7f98-4dc6-b231-1c483292084a
spl set id: 7914cbe6-4fd5-42a7-8b46-aed65b4cc2ef

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.